These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

883 related articles for article (PubMed ID: 12553040)

  • 1. Mapping the methylation pattern by bisulfite genomic sequencing of the E-cadherin promoter CpG island in nasopharyngeal carcinoma.
    Kao RH; Huang LC; Hsu YH
    Anticancer Res; 2002; 22(6C):4109-13. PubMed ID: 12553040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CpG hypermethylation of promoter region and inactivation of E-cadherin gene in human bladder cancer.
    Ribeiro-Filho LA; Franks J; Sasaki M; Shiina H; Li LC; Nojima D; Arap S; Carroll P; Enokida H; Nakagawa M; Yonezawa S; Dahiya R
    Mol Carcinog; 2002 Aug; 34(4):187-98. PubMed ID: 12203370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of E-cadherin and beta-catenin with metastasis in nasopharyngeal carcinoma.
    Li Z; Ren Y; Lin SX; Liang YJ; Liang HZ
    Chin Med J (Engl); 2004 Aug; 117(8):1232-9. PubMed ID: 15361301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promoter methylation regulates cadherin switching in squamous cell carcinoma.
    Chen Q; Lipkina G; Song Q; Kramer RH
    Biochem Biophys Res Commun; 2004 Mar; 315(4):850-6. PubMed ID: 14985090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [CpG island methylation of E-cadherin gene promoter in gastric carcinoma].
    Zhou YN; Xu CP; Han B; Ji R
    Ai Zheng; 2005 Oct; 24(10):1220-4. PubMed ID: 16219136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA methyltransferase 1 expression and promoter methylation of E-cadherin in mucoepidermoid carcinoma.
    Shieh YS; Shiah SG; Jeng HH; Lee HS; Wu CW; Chang LC
    Cancer; 2005 Sep; 104(5):1013-21. PubMed ID: 15999364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypermethylation of epithelial-cadherin gene promoter is associated with Epstein-Barr virus in nasopharyngeal carcinoma.
    Niemhom S; Kitazawa S; Kitazawa R; Maeda S; Leopairat J
    Cancer Detect Prev; 2008; 32(2):127-34. PubMed ID: 18632221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of E-cadherin expression resulting from promoter hypermethylation in oral tongue carcinoma and its prognostic significance.
    Chang HW; Chow V; Lam KY; Wei WI; Yuen A
    Cancer; 2002 Jan; 94(2):386-92. PubMed ID: 11900224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E-cadherin promoter.
    Lim SO; Gu JM; Kim MS; Kim HS; Park YN; Park CK; Cho JW; Park YM; Jung G
    Gastroenterology; 2008 Dec; 135(6):2128-40, 2140.e1-8. PubMed ID: 18801366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The correlation between CpG methylation on promoter and protein expression of E-cadherin in oral squamous cell carcinoma.
    Yeh KT; Shih MC; Lin TH; Chen JC; Chang JY; Kao CF; Lin KL; Chang JG
    Anticancer Res; 2002; 22(6C):3971-5. PubMed ID: 12553020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mapping of the methylation pattern of the MUC2 promoter in pancreatic cancer cell lines, using bisulfite genomic sequencing.
    Hamada T; Goto M; Tsutsumida H; Nomoto M; Higashi M; Sugai T; Nakamura S; Yonezawa S
    Cancer Lett; 2005 Sep; 227(2):175-84. PubMed ID: 16112420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analyses of promoter hypermethylation for RUNX3 and other tumor suppressor genes in nasopharyngeal carcinoma.
    Tan SH; Ida H; Goh BC; Hsieh W; Loh M; Ito Y
    Anticancer Res; 2006; 26(6B):4287-92. PubMed ID: 17201146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progression of carcinoma cells is associated with alterations in chromatin structure and factor binding at the E-cadherin promoter in vivo.
    Hennig G; Behrens J; Truss M; Frisch S; Reichmann E; Birchmeier W
    Oncogene; 1995 Aug; 11(3):475-84. PubMed ID: 7630631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA methylation paradigm shift: 15-lipoxygenase-1 upregulation in prostatic intraepithelial neoplasia and prostate cancer by atypical promoter hypermethylation.
    Kelavkar UP; Harya NS; Hutzley J; Bacich DJ; Monzon FA; Chandran U; Dhir R; O'Keefe DS
    Prostaglandins Other Lipid Mediat; 2007 Jan; 82(1-4):185-97. PubMed ID: 17164146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Quantitative microarray-based DNA methylation analysis of E-cadherin gene promoter in acute leukemia].
    Chen BA; Zhang F; Wang Y; Zheng WL; Du J; Gao C; Ding JH; Sun YY; Cheng J; Wang J; Zhao G; Chen NN; Lu ZH
    Zhonghua Zhong Liu Za Zhi; 2007 Jan; 29(1):41-4. PubMed ID: 17575692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. E-cadherin expression is silenced by 5' CpG island methylation in acute leukemia.
    Corn PG; Smith BD; Ruckdeschel ES; Douglas D; Baylin SB; Herman JG
    Clin Cancer Res; 2000 Nov; 6(11):4243-8. PubMed ID: 11106238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic control of the E-cadherin gene (CDH1) by CpG methylation in colectomy samples of patients with ulcerative colitis.
    Azarschab P; Porschen R; Gregor M; Blin N; Holzmann K
    Genes Chromosomes Cancer; 2002 Oct; 35(2):121-6. PubMed ID: 12203775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypermethylation of an E-cadherin (CDH1) promoter region in high grade transitional cell carcinoma of the bladder comprising carcinoma in situ.
    Horikawa Y; Sugano K; Shigyo M; Yamamoto H; Nakazono M; Fujimoto H; Kanai Y; Hirohashi S; Kakizoe T; Habuchi T; Kato T
    J Urol; 2003 Apr; 169(4):1541-5. PubMed ID: 12629411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Studies on gene expression and the 5' CpG islands methylation status of E-cadherin in acute myeloid leukemia].
    Gao F; Li Y; Liu W; Lu XL; Li X; Wang PP; Liu YP
    Zhonghua Xue Ye Xue Za Zhi; 2006 Jan; 27(1):25-7. PubMed ID: 16732935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promoter hypermethylation profile of kidney cancer.
    Dulaimi E; Ibanez de Caceres I; Uzzo RG; Al-Saleem T; Greenberg RE; Polascik TJ; Babb JS; Grizzle WE; Cairns P
    Clin Cancer Res; 2004 Jun; 10(12 Pt 1):3972-9. PubMed ID: 15217927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.